NCT06080503View on ClinicalTrials.gov

Phase II Randomized Study of Hypofractionated Versus Conventional Radiotherapy

NARecruitingINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

March 14, 2024

Primary Completion Date

November 1, 2028

Study Completion Date

March 14, 2029

Conditions
Laryngeal Carcinoma
Interventions
RADIATION

LT-SABR

42.5 Gy in 5 fractions Low-risk: twice/week Moderate-risk: weekly

RADIATION

IMRT

63 Gy in 28 fractions (T1) 65.25 Gy in 29 fractions (T2)

Trial Locations (1)

75390

RECRUITING

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER